Assessment of Hypertensive Retinopathy Severity and Associated Factors in Adult Patients at Ophthalmic Clinics in Northern Ethiopia: A Multicenter Cross-Sectional Analysis - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessment of Hypertensive Retinopathy Severity and Associated Factors in Adult Patients at Ophthalmic Clinics in Northern Ethiopia: A Multicenter Cross-Sectional Analysis

  • By

  • Yitayal Abebe Gudayneh

  • Abebech Tewabe Gelaye

  • Sisay Eshete Tadesse

  • April 21, 2026

Share

  • 1

    Hypertensive retinopathy (HR) is a significant complication of hypertension, indicating damage to retinal vasculature due to high blood pressure.

  • 2

    The study assessed HR severity and associated factors among adult patients in ophthalmic clinics in Northern Ethiopia, revealing a high prevalence.

  • 3

    Severe HR is linked to poorly controlled blood pressure, long duration of hypertension, and comorbid conditions like diabetes and dyslipidemia.

  • 4

    The multicenter study involved five specialized hospitals, with a final sample size of 414 adult patients diagnosed with HR.

  • 5

    Understanding determinants of HR severity is crucial for early identification of high-risk patients and prevention of visual impairment.

Original Source(s)

Assessment of Hypertensive Retinopathy Severity and Associated Factors in Adult Patients at Ophthalmic Clinics in Northern Ethiopia: A Multicenter Cross-Sectional Analysis

  • by Yitayal Abebe Gudayneh, Abebech Tewabe Gelaye, Sisay Eshete Tadesse

  • April 21, 2026

Related Content

Semaglutide Linked to NAION Risk

A retrospective database study found a low absolute incidence but higher relative hazard of ischemic optic neuropathy following semaglutide initiation.

Diabetic Retinal Disease Rates Narrow by Diabetes Type

US claims data showed rising prevalence of diabetic retinal disease in type 1 and type 2 diabetes, while incidence declined in type 1 diabetes and moved closer to type 2 rates by 2022.

AI Boosts Diabetic Eye Care Access

Recent study highlights how integrated AI-assisted DR screening in primary care clinics can improve access and decrease disparity

  • May 5, 2026

  • 3 min